Home/Filings/4/0001441844-11-000004
4//SEC Filing

MCKINNEY ROBERT A 4

Accession 0001441844-11-000004

CIK 0000835887other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:33 PM ET

Size

12.0 KB

Accession

0001441844-11-000004

Insider Transaction Report

Form 4
Period: 2011-01-03
MCKINNEY ROBERT A
Chief Financial Officer
Transactions
  • Award

    ESPP (right to buy)

    2011-01-03+6,3376,337 total
    Exercise: $5.46From: 2011-07-01Exp: 2011-07-01Common Stock (6,337 underlying)
  • Tax Payment

    Common Stock

    2011-01-03$5.68/sh2,473$14,04744,886 total
  • Exercise/Conversion

    ESPP (right to buy)

    2011-01-032,7150 total
    Exercise: $4.83From: 2011-01-01Exp: 2011-01-01Common Stock (2,715 underlying)
  • Exercise/Conversion

    Common Stock

    2011-01-03$4.83/sh+2,715$13,10847,359 total
Footnotes (5)
  • [F1]Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise.
  • [F2]Includes shares of common stock acquired from the non-reportable exercise of a Grant under the Qualified Employee Stock Purchase Plan.
  • [F3]Granted under the Company's Non-Qualified Employeee Stock Purchase Plan.
  • [F4]The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date. The number of shares acquired upon exercise is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date.
  • [F5]The option will be exercisable for that number of shares equal to the option amount (25% of the optionee's quarterly salary less $6,250) divided by the lesser of the market value of the common stock on the grant date or 85% of the market value on the exercise date.

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeother

Related Parties

1
  • filerCIK 0001257410

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:33 PM ET
Size
12.0 KB